Jan Poleszczuk

Has grant

Assistant Professor

Nalecz Institute of Biocybernetics and Biomedical Engineering, Polish Academy of Sciences

Poland

Research Interests

Explore related searches

Professors in Poland Professors in Immunology Immunology professors in Poland

Contact this professor

Get a free first email built on one of their papers, ready for you to edit and send yourself.

About

Jan Poleszczuk is an Assistant Professor at the Nalecz Institute of Biocybernetics and Biomedical Engineering, Polish Academy of Sciences. His research focus includes advanced gastrointestinal stromal tumors, triple-negative breast cancer treatment patterns, and the effects of checkpoint inhibitors in melanoma. He employs mathematical modeling in his studies, investigating topics such as tumor cell radiosensitivity and renal dialysis therapies. His recent publications reflect a commitment to integrating clinical trials with innovative therapeutic approaches.

Recent Grants

Grant: Close

A sensitivity study based on a variance for systems of differential equations with delayed argument.

Open Date: 2012-09-25

Close Date: 2015-09-24

Articles (12)

Year:

2025

Year:

2024

Year:

2023

Year:

2023

Year:

2022

Year:

2022

Year:

2022

Year:

2022

Year:

2022

Year:

2021

Year:

2021

Year:

2021

Collaborators (20)

Malgorzata Debowska

Nalecz Institute of Biocybernetics and Biomedical Engineering, Polish Academy of Sciences

POLAND

Jan Poleszczuk

Research Interests

Explore related searches

Contact this professor

About

Recent Grants

Articles (12)

Avelumab plus axitinib in patients with advanced gastrointestinal stromal tumor

Retrospective Observational Study to Determine the Epidemiology and Treatment Patterns of Patients with Triple-Negative Breast Cancer

Carbonic Anhydrase IX Suppression Shifts Partial Response to Checkpoint Inhibitors into Complete Tumor Eradication: Model-Based Investigation

Incidental Diagnosis of Urothelial Bladder Cancer: Associations with Overall Survival

Immune-Related Thyroid Adverse Events Predict Response to PD-1 Blockade in Patients with Melanoma

Classical mathematical models for prediction of response to chemotherapy and immunotherapy

Cellular plasticity upon proton irradiation determines tumor cell radiosensitivity

Dialysis therapies: Investigation of transport and regulatory processes using mathematical modelling

Stereotactic radiotherapy for soft tissue and bone sarcomas: real-world evidence

Combined Preoperative Hypofractionated Radiotherapy With Doxorubicin-Ifosfamide Chemotherapy in Marginally Resectable Soft Tissue Sarcomas: Results of a Phase 2 Clinical Trial

Changes in Subendocardial Viability Ratio in Traumatic Brain Injury Patients

Radiotherapy in the Management of Pediatric and Adult Osteosarcomas: A Multi-Institutional Cohort Analysis

Collaborators (20)

Malgorzata Debowska

Paweł Sobczuk

Paweł Teterycz

Heiko Enderling

Waniewski Jacek

Tomasz Skóra

Kateřina Staňková

Aleksandra Napieralska

Cläre von Neubeck

Roman Sosnowski

Marzanna Chojnacka

Joanna Stachowska-Pietka

Tomasz Switaj

Chiara Maria Lavinia Loeffler

Mauro Pietribiasi

Claudia Peitzsch

Armin Lühr

Magdalena Rosińska

Leszek Pstras

Andrzej Jaroszyński

Make your next move.